After two cycles of [177Lu]Lu-DOTA-TATE therapy, tumor growth was halted (TTV decreased from 385 mL to 273 mL) and the thyroglobulin tumor marker level decreased from 606 ng/ml to 273 ng/mL. The gene discussed is TG; the disease is neoplasm.